We quantified the community-level impact of routinely treating symptomatic P. vivax cases with PQ or TQ using an existing agent-based model.
- All regimens can achieve a similar impact
- Drug adherence and eligibility criteria hamper impact
- Impact decreases with increasing transmission intensity
